Endovia Health Sciences, Inc.
EDVA
30 hedge funds and large institutions have $1.04M invested in Endovia Health Sciences, Inc. in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 6 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
16% more capital invested
Capital invested by funds: $903K → $1.04M (+$142K)
0% less ownership
Funds ownership: 0.05% → 0.04% (-0%)
3% less funds holding
Funds holding: 31 → 30 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$52.5K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$28.5K |
| 3 |
Renaissance Technologies
New York
|
+$21K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$20.4K |
| 5 |
Jane Street
New York
|
+$8.26K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$29.3K |
| 2 |
AWS
Atria Wealth Solutions
New York
|
-$6.9K |
| 3 |
BlackRock
New York
|
-$5.89K |
| 4 |
VF
Virtu Financial
New York
|
-$5K |
| 5 |
HF
HRT Financial
New York
|
-$3K |
EDVA Hedge Fund Activity: Q3 2024 in Review
30 of the 6,977 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q3 2024, worth a combined $1.04M — up 16% from $903K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of EDVA and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 9 added.
The largest buyer was UBS Group, opening a new position worth an estimated $52.5K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $29.3K sold.
- 30 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q3 2024, down from 31 in Q2 2024.
- Funds reported $1.04M of Endovia Health Sciences, Inc. stock for Q3 2024, up 16% quarter-over-quarter.
- 5 funds opened new Endovia Health Sciences, Inc. positions in Q3 2024 and 6 closed out, a net change of -1 holder.
- The largest Endovia Health Sciences, Inc. buyer in Q3 2024 was UBS Group, an estimated $52.5K added.
- The largest Endovia Health Sciences, Inc. seller in Q3 2024 was Bridgeway Capital Management, an estimated $29.3K sold.
Based on aggregated 13F filings for Q3 2024.